DT-Web

DB00221 - Isoetharine


Identification
Name Isoetharine
Accession Number DB00221 (APRD00750)
Type small molecule
Description Isoetharine is a selective adrenergic beta-2 agonist used as fast acting bronchodilator for emphysema, bronchitis and asthma. [PubChem]
Structure
MOL SDF PDB SMILES InChI
Categories (*)
Molecular Weight 239.3107
Groups approved
Monoisotopic Weight 239.152143543
Pharmacology
Indication For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.
Mechanism of action The pharmacologic effects of isoetharine are attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
Absorption Not Available
Protein binding Not Available
Biotransformation Not Available
Route of elimination Not Available
Toxicity Signs of overdose include tachycardia, palpitations, nausea, headache, and epinephrine-like side effects.
Affected organisms
  • Humans and other mammals
Interactions
Drug Interactions
Drug Mechanism of interaction
Entacapone Entacapone increases the effect and toxicity of the sympathomimetic, isoetharine.
Food Interactions Not Available

Targets


Beta-1 adrenergic receptor
Name Beta-1 adrenergic receptor
Gene Name ADRB1
Pharmacological action yes
Actions agonist
References
  • Rodrigues LL, Oliveira MC, Pelegrini-da-Silva A, de Arruda Veiga MC, Parada CA, Tambeli CH: Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain. 2006 Dec;7(12):929-36. - Pubmed
  • Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I: Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007 Jul 12;81(5):399-404. Epub 2007 Jun 16. - Pubmed
  • Terra SG, McGorray SP, Wu R, McNamara DM, Cavallari LH, Walker JR, Wallace MR, Johnson BD, Bairey Merz CN, Sopko G, Pepine CJ, Johnson JA: Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond). 2005 Jul;29(7):746-54. - Pubmed
  • Burniston JG, Tan LB, Goldspink DF: Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats. Exp Physiol. 2006 Nov;91(6):1041-9. Epub 2006 Sep 14. - Pubmed
  • Muszkat M: Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9. Clin Pharmacol Ther. 2007 Aug;82(2):215-8. Epub 2007 Feb 28. - Pubmed
DTHybrid score 0.4658

Predictions


Id Partner name Gene Name Score
766 Beta-2 adrenergic receptor ADRB2 0.2313
1517 Beta-3 adrenergic receptor ADRB3 0.07
4119 Cytochrome P450 2D6 CYP2D6 0.0536
1588 Multidrug resistance protein 1 ABCB1 0.029
556 Alpha-1A adrenergic receptor ADRA1A 0.0283
320 5-hydroxytryptamine 1A receptor HTR1A 0.0264
4200 Cytochrome P450 1A2 CYP1A2 0.0179
318 Alpha-2A adrenergic receptor ADRA2A 0.0165
6144 Solute carrier family 22 member 2 SLC22A2 0.0157
101 Potassium voltage-gated channel subfamily H member 2 KCNH2 0.0153
4512 Cytochrome P450 3A4 CYP3A4 0.0152
885 5-hydroxytryptamine 1B receptor HTR1B 0.0147
4292 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase lpxA 0.0124
3076 Antigen 85-C fbpC 0.0122
632 Alpha-1B adrenergic receptor ADRA1B 0.012
3810 Catechol O-methyltransferase COMT 0.0109
629 Alpha-2B adrenergic receptor ADRA2B 0.0106
6024 Cytochrome P450 1A1 CYP1A1 0.0103
3941 Amine oxidase [flavin-containing] A MAOA 0.0102
540 Sodium-dependent noradrenaline transporter SLC6A2 0.0096
6016 Cytochrome P450 2C19 CYP2C19 0.0096
1181 Alpha-1-acid glycoprotein 1 ORM1 0.0093
6847 Lactase-phlorizin hydrolase LCT 0.0093
378 Alpha-2C adrenergic receptor ADRA2C 0.0088
1820 Beta-nerve growth factor NGF 0.0085
6145 Solute carrier family 22 member 1 SLC22A1 0.0085
4145 Phosphatidylinositol 3-kinase regulatory subunit beta PIK3R2 0.0077
4146 Phosphatidylinositol 3-kinase regulatory subunit gamma PIK3R3 0.0077
828 Phenylalanine-4-hydroxylase PAH 0.0077
3109 Phenylalanine-4-hydroxylase phhA 0.0077
789 Alpha-1D adrenergic receptor ADRA1D 0.0074
1281 Phosphatidylinositol 3-kinase regulatory subunit alpha PIK3R1 0.0065
824 Sodium-dependent serotonin transporter SLC6A4 0.0061
777 Tumor necrosis factor TNF 0.0058
713 Sodium-dependent dopamine transporter SLC6A3 0.0055
23 D(1A) dopamine receptor DRD1 0.0054
2300 Lysozyme E 0.0052
3633 Lysozyme R 0.0052
5597 Lysozyme 17 0.0052
1176 Mitogen-activated protein kinase 1 MAPK1 0.0043
118 Organic cation/carnitine transporter 2 SLC22A5 0.004
4757 Cytochrome P450 2C9 CYP2C9 0.0036
1374 Natriuretic peptides B NPPB 0.0032
1827 Gap junction alpha-1 protein GJA1 0.0032
1908 Vascular cell adhesion protein 1 VCAM1 0.0032
6164 POU domain, class 5, transcription factor 1 POU5F1 0.0031
131 Synaptic vesicular amine transporter SLC18A2 0.003
6107 Cytochrome P450 3A7 CYP3A7 0.0029
3876 Aromatic-L-amino-acid decarboxylase DDC 0.0028
4118 Cytochrome P450 3A5 CYP3A5 0.0027
4160 Voltage-dependent calcium channel subunit alpha-2/delta-2 CACNA2D2 0.0027
194 NADH dehydrogenase [ubiquinone] 1 subunit C2 NDUFC2 0.0026
6147 Solute carrier family 22 member 3 SLC22A3 0.0026
964 Voltage-dependent T-type calcium channel subunit alpha-1H CACNA1H 0.0025
3939 Amine oxidase [flavin-containing] B MAOB 0.0023
183 Vascular endothelial growth factor A VEGFA 0.0023
233 Potassium channel subfamily K member 2 KCNK2 0.0023
6151 Monocarboxylate transporter 10 SLC16A10 0.0021
4114 Voltage-dependent L-type calcium channel subunit beta-3 CACNB3 0.0019
4112 Voltage-dependent L-type calcium channel subunit beta-4 CACNB4 0.0019
1360 Sphingomyelin phosphodiesterase SMPD1 0.0019
6013 Cytochrome P450 2E1 CYP2E1 0.0019
502 5-hydroxytryptamine 2A receptor HTR2A 0.0019
492 Histamine H1 receptor HRH1 0.0018
4113 Voltage-dependent L-type calcium channel subunit alpha-1F CACNA1F 0.0018
333 Voltage-dependent L-type calcium channel subunit beta-1 CACNB1 0.0017
158 Sodium channel protein type 1 subunit alpha SCN1A 0.0017
3947 Xanthine dehydrogenase/oxidase XDH 0.0016
1256 5-hydroxytryptamine 6 receptor HTR6 0.0016
6025 UDP-glucuronosyltransferase 1-4 UGT1A4 0.0015
4110 Voltage-dependent L-type calcium channel subunit beta-2 CACNB2 0.0015
4115 Voltage-dependent L-type calcium channel subunit alpha-1D CACNA1D 0.0015
4111 Voltage-dependent L-type calcium channel subunit alpha-1S CACNA1S 0.0015
124 Histamine H2 receptor HRH2 0.0014
478 Voltage-dependent L-type calcium channel subunit alpha-1C CACNA1C 0.0014
716 5-hydroxytryptamine 7 receptor HTR7 0.0014
6432 Transporter snf 0.0014
4924 Cytochrome P450 2C8 CYP2C8 0.0014
436 5-hydroxytryptamine 2B receptor HTR2B 0.0013
432 D(4) dopamine receptor DRD4 0.0013
20 Prostaglandin G/H synthase 1 PTGS1 0.0012
638 D(3) dopamine receptor DRD3 0.0012
590 5-hydroxytryptamine 2C receptor HTR2C 0.0012
831 D(2) dopamine receptor DRD2 0.001
6106 Cytochrome P450 2C18 CYP2C18 0.001
274 Muscarinic acetylcholine receptor M5 CHRM5 0.001
833 Organic cation/carnitine transporter 1 SLC22A4 0.001
587 Serum albumin ALB 0.0009
450 Muscarinic acetylcholine receptor M4 CHRM4 0.0009
51 Muscarinic acetylcholine receptor M3 CHRM3 0.0008
617 Muscarinic acetylcholine receptor M2 CHRM2 0.0008
5718 Cytochrome P450 2A6 CYP2A6 0.0008
103 Muscarinic acetylcholine receptor M1 CHRM1 0.0008
6030 Cytochrome P450 2B6 CYP2B6 0.0007
↑